R-Tech Ueno Initiates A Phase I Clinical Study Of RK-023 For The Treatment Of Hypotrichosis Of The Eyelashes
R-Tech Ueno (JASDAQ:4573) is pleased to announce the initiation of a Phase I clinical study of RK-023, a new compound that is being developed for the treatment of hypotrichosis of the eyelashes(1). The details of the trial are summarized below...